Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Lung Non-Small Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07554846
What this trial is testing

Comparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant Immunotherapy for Resectable Stage II-IIIA NSCLC

Who this might be right for
Resectable Stage II-IIIa NSCLC
Fudan University 759
Testing effectiveness (Phase 2)Looking for participantsNCT07354061
What this trial is testing

Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC)

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
Tang-Du Hospital 20
Not applicableLooking for participantsNCT05167487
What this trial is testing

Pathological Response After Neoadjuvant Treatment on NSCLC

Who this might be right for
Stage IIIA Non-small Cell Lung Cancer
Fundación GECP 150
Not applicableLooking for participantsNCT06634199
What this trial is testing

Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer Stage IIIPDL1 Gene Mutation
Fundación GECP 50
Testing effectiveness (Phase 2)Looking for participantsNCT07122687
What this trial is testing

IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 170
Testing effectiveness (Phase 2)Active Not RecruitingNCT05500092
What this trial is testing

An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer

Who this might be right for
Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
Montefiore Medical Center 17
Not applicableLooking for participantsNCT04324151
What this trial is testing

Pembrolizumab Combined With Double Platinum Based Chemotherapy for Potentially Resectable NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Hunan Province Tumor Hospital 70
Testing effectiveness (Phase 2)Ended earlyNCT04422392
What this trial is testing

Neoadjuvant PD-1 Antibody Plus Chemotherapy in Resectable Stage IIIA-N2 Non-Small-Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 93
Testing effectiveness (Phase 2)Ended earlyNCT04638582
What this trial is testing

Pembrolizumab as Neoadjuvant Therapy for Resectable Stage IA3 to IIA Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer, Nonsmall Cell
McGill University Health Centre/Research Institute of the McGill University Health Centre 6
Not applicableWithdrawnNCT01398124
What this trial is testing

Cyclin B1 Peptide-Pulsed Autologous Dendritic Cell Vaccine for Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Milton S. Hershey Medical Center
Testing effectiveness (Phase 2)Study completedNCT05775796
What this trial is testing

Evaluate the Efficacy and Safety of Serplulimab Plus Chemotherapy in Neoadjuvant and Adjuvant Treatment of Resectable NSCLC (ECTOP-1013)

Who this might be right for
Non-small Cell Lung CancerStage II-IIIAImmunotherapy+1 more
Fudan University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06734182
What this trial is testing

Neoadjuvant Envafolimab Plus Disitamab Vedotin and Carboplatin in Resectable HER2-Mutant Non-Small-Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Guangdong Provincial People's Hospital 25
Not applicableNot Yet RecruitingNCT07760519
What this trial is testing

Observational PMS Study Assessing Durvalumab Safety in Indian Adults With Resectable NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 78
Not applicableLooking for participantsNCT06743581
What this trial is testing

Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerImmunotherapyNeoadjuvant Therapy
Centre hospitalier de l'Université de Montréal (CHUM) 24
Large-scale testing (Phase 3)UnknownNCT06485557
What this trial is testing

A Prospective Cohort Study of Neoadjuvant Chemotherapy Plus Sintillumab in the Treatment of Resectable NSCLC

Who this might be right for
Resectable Non-small Cell Lung Cancer
Tang-Du Hospital 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07358689
What this trial is testing

Toripalimab Combined With Platinum-based Chemotherapy With or Without H1 Receptor Antagonist in the Perioperative Treatment of Resectable Non-small Cell Lung Cancer

Who this might be right for
NSCLC
Tianjin Medical University Cancer Institute and Hospital 120
Testing effectiveness (Phase 2)Study completedNCT05577702
What this trial is testing

Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
BeiGene 121
Large-scale testing (Phase 3)Study completedNCT00136890
What this trial is testing

PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers

Who this might be right for
Non-small-cell Lung Carcinoma
Ontario Clinical Oncology Group (OCOG) 337
Not applicableUnknownNCT06250829
What this trial is testing

Model to Predict pCR and IrAEs in Early Stage Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage IB (Resectable)Non-small Cell Lung Cancer Stage II (Resectable)Non-small Cell Lung Cancer Stage ⅢA (Resectable)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 60
Testing effectiveness (Phase 2)Looking for participantsNCT06918132
What this trial is testing

Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage IB Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8+2 more
Mayo Clinic 60
Next Page